Nexalin Technology (NASDAQ:NXL – Get Free Report) and Precision Optics (NASDAQ:POCI – Get Free Report) are both small-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, valuation, analyst recommendations, profitability and risk.
Volatility & Risk
Nexalin Technology has a beta of 6.34, suggesting that its share price is 534% more volatile than the S&P 500. Comparatively, Precision Optics has a beta of 0.12, suggesting that its share price is 88% less volatile than the S&P 500.
Valuation and Earnings
This table compares Nexalin Technology and Precision Optics’ revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Nexalin Technology | $110,000.00 | 89.28 | -$4.65 million | N/A | N/A |
| Precision Optics | $21.05 million | 1.59 | -$140,000.00 | ($0.30) | -18.37 |
Profitability
This table compares Nexalin Technology and Precision Optics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Nexalin Technology | -4,185.46% | -122.57% | -97.00% |
| Precision Optics | -8.93% | -21.74% | -13.02% |
Institutional and Insider Ownership
0.7% of Nexalin Technology shares are held by institutional investors. Comparatively, 13.7% of Precision Optics shares are held by institutional investors. 27.7% of Nexalin Technology shares are held by company insiders. Comparatively, 16.3% of Precision Optics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Analyst Recommendations
This is a breakdown of recent ratings and recommmendations for Nexalin Technology and Precision Optics, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Nexalin Technology | 0 | 0 | 0 | 0 | N/A |
| Precision Optics | 0 | 0 | 0 | 0 | N/A |
Summary
Precision Optics beats Nexalin Technology on 6 of the 9 factors compared between the two stocks.
About Nexalin Technology
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. In addition, it designs and develops Generation 2 and Generation 3, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, Alzheimer's disease, and dementia. The company is based in Houston, Texas.
About Precision Optics
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.
Receive News & Ratings for Nexalin Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nexalin Technology and related companies with MarketBeat.com's FREE daily email newsletter.
